Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$397M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
AT&T
T
|
+$295M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$274M |
| 5 |
Walmart
WMT
|
+$273M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.19B |
| 2 |
Lam Research
LRCX
|
+$379M |
| 3 |
Apple
AAPL
|
+$367M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$320M |
| 5 |
Boeing
BA
|
+$299M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Industrials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Vital Energy
VTLE
$635M
| $5.19M | ﹤0.01% |
113,897
-133,070
| -54% | -$6.06M |
|
|
FORG
1852
DELISTED
ForgeRock, Inc.
FORG
| $5.19M | ﹤0.01% |
251,741
+194,709
| +341% | +$4.01M |
|
1853
Mersana Therapeutics
MRSN
$35.6M
| $5.18M | ﹤0.01% |
50,442
-96,099
| -66% | -$9.87M |
|
1854
Stock Yards Bancorp
SYBT
$2.27B
| $5.16M | ﹤0.01% |
93,532
+89,988
| +2,539% | +$4.96M |
|
1855
BridgeBio Pharma
BBIO
$9.79B
| $5.15M | ﹤0.01% |
310,569
+226,392
| +269% | +$3.75M |
|
|
BLUE
1856
DELISTED
bluebird bio
BLUE
| $5.15M | ﹤0.01% |
80,958
+44,804
| +124% | +$2.85M |
|
1857
Clean Energy Fuels
CLNE
$526M
| $5.14M | ﹤0.01% |
1,179,801
+1,148,793
| +3,705% | +$5.01M |
|
1858
Harrow
HROW
$1.46B
| $5.14M | ﹤0.01% |
243,067
+91,564
| +60% | +$1.94M |
|
1859
Quaker Houghton
KWR
$2.46B
| $5.14M | ﹤0.01% |
25,955
+21,915
| +542% | +$4.34M |
|
1860
Warrior Met Coal
HCC
$3.04B
| $5.14M | ﹤0.01% |
139,930
-287,447
| -67% | -$10.6M |
|
|
FWAC
1861
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
| $5.13M | ﹤0.01% |
502,416
-858,335
| -63% | -$8.76M |
|
|
TGAA
1862
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
| $5.13M | ﹤0.01% |
491,500
-540,003
| -52% | -$5.63M |
|
1863
DocGo
DCGO
$150M
| $5.12M | ﹤0.01% |
591,571
+476,274
| +413% | +$4.12M |
|
|
DEVS
1864
DevvStream Corp. Common Stock
DEVS
$9.28M
| $5.1M | ﹤0.01% |
49,000
-9,067
| -16% | -$943K |
|
1865
Cadre Holdings
CDRE
$1.32B
| $5.09M | ﹤0.01% |
236,190
-42,406
| -15% | -$914K |
|
|
CRON
1866
Cronos Group
CRON
$969M
| $5.08M | ﹤0.01% |
2,620,214
+804,957
| +44% | +$1.56M |
|
1867
Motorcar Parts of America
MPAA
$305M
| $5.07M | ﹤0.01% |
+681,087
| New | +$5.07M |
|
1868
AdaptHealth
AHCO
$1.26B
| $5.04M | ﹤0.01% |
405,498
-380,633
| -48% | -$4.73M |
|
1869
Arbutus Biopharma
ABUS
$855M
| $5.03M | ﹤0.01% |
1,660,566
-192,149
| -10% | -$582K |
|
1870
Zeta Global
ZETA
$4.84B
| $5.02M | ﹤0.01% |
463,543
-713,141
| -61% | -$7.72M |
|
1871
Vanguard Dividend Appreciation ETF
VIG
$97.5B
| $4.98M | ﹤0.01% |
+32,327
| New | +$4.98M |
|
1872
Lumen
LUMN
$6.21B
| $4.96M | ﹤0.01% |
1,873,101
-7,986,034
| -81% | -$21.2M |
|
|
DPCS
1873
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
| $4.96M | ﹤0.01% |
475,000
-630,600
| -57% | -$6.59M |
|
1874
Allogene Therapeutics
ALLO
$251M
| $4.96M | ﹤0.01% |
1,002,996
-2,272,128
| -69% | -$11.2M |
|
|
BNR
1875
Burning Rock Biotech
BNR
$89.4M
| $4.95M | ﹤0.01% |
175,988
+53,001
| +43% | +$1.49M |
|